Zithromax-SR 2g, Special Investigation (Regulatory Post Marketing Commitment Plan)
NCT00998309 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 502
Last updated 2012-05-01
Summary
To collect the efficacy and safety information of Zithromax-SR related to their appropriate use in daily practice.
Conditions
Interventions
- DRUG
-
Azithromycin SR
Zithromax SR 2g, taking once for treatment.
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Pfizer CT.gov Call Center · Pfizer
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-10-31
- Primary Completion
- 2011-01-31
- Completion
- 2011-01-31
More Related Trials
-
An Open Label, Randomized, Crossover Study To Estimate The Pharmacokinetics And Evaluate The Safety Following A Single Dose Of Azithromycin 2g Extended-Release Powder For Oral Suspension With A 3-Day Dosing Regimen Of Azithromycin 500mg Tablet In Chinese Healthy Male Subjects
NCT00879983 ·Status: COMPLETED ·Phase: PHASE1
-
Cefixime / Azithromycin pK Study
NCT02708992 ·Status: COMPLETED ·Phase: PHASE1
-
Drug Use Investigation Of Azithromycin IV For Pneumonia Or Pelvic Inflammatory Disease (Regulatory Post Marketing Commitment Plan)
NCT01671280 ·Status: COMPLETED
-
A Relative Bioavailability Study of 200mg/5 mL Azithromycin Oral Suspension Under Fasting Conditions
NCT00830206 ·Status: COMPLETED ·Phase: PHASE1
-
Special Investigation Of Azithromycin IV For Legionnaires' Disease (Regulatory Post Marketing Commitment Plan)
NCT01784770 ·Status: COMPLETED
-
Efficacy of Macrolide Immunomodulation in Severe Sepsis.
NCT00708799 ·Status: TERMINATED ·Phase: PHASE2
-
Zoliflodacin in Uncomplicated Gonorrhoea
NCT03959527 ·Status: COMPLETED ·Phase: PHASE3
-
A Single and Repeat Dose PK/PD Study to Characterise Biomarker Response in Healthy Subjects Treated With Azithromycin
NCT01416350 ·Status: COMPLETED ·Phase: PHASE1
-
Comparative Bioavailability Study of Azithromycin 200mg/5mL Suspension Following a 600mg Dose Under Fed Conditions
NCT00875966 ·Status: COMPLETED ·Phase: PHASE1
-
Zithromax EV in Community-Acquired Pneumonia (CAP)
NCT00137007 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of 14-day Concomitant Therapy for Refractory Helicobacter Pylori Infection
NCT05133193 ·Status: UNKNOWN ·Phase: NA
-
Azithromycin for COVID-19 Treatment in Outpatients Nationwide
NCT04332107 ·Status: TERMINATED ·Phase: PHASE3
-
A Multicenter, Randomized, Double-Blind, Double-Dummy Study Of Azithromycin SR Versus Amoxicillin For The Treatment Of Strep Throat In Children
NCT00643149 ·Status: COMPLETED ·Phase: PHASE3
-
A Trial Of Azithromycin SR For The Treatment Of Acute Bronchitis And Secondary Infection Of Chronic Respiratory Diseases
NCT00360464 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Combination Therapies for Gonorrhea Treatment
NCT00926796 ·Status: COMPLETED ·Phase: PHASE4
-
A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for the Treatment of Acute Symptoms of Chronic Bronchitis
NCT00644449 ·Status: COMPLETED ·Phase: PHASE3
-
A Three-part Study to Determine the Safety, Tolerability and Pharmacokinetics of GSK1322322 in Healthy Volunteers and Healthy Male Japanese Subjects
NCT01818011 ·Status: TERMINATED ·Phase: PHASE1
-
Azithromycin in the Treatment of M. Avium Complex Lung Disease
NCT00599079 ·Status: COMPLETED ·Phase: PHASE4
-
Skin Inflammation and PK of Azithromycin
NCT06170983 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Safety and Efficacy Study of Rifalazil for the Treatment of Chlamydia Trachomatis Infection in Women
NCT01631201 ·Status: COMPLETED ·Phase: PHASE2
-
Use of Azithromycin and Rifabutin Administered 3 Times Weekly for the Treatment of M. Avium Complex (MAC) Lung Disease
NCT00598962 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacokinetics and Safety Study of Rifamycin SV-MMX® 600 mg Tablets After Single and Multiple t.i.d. Doses in Healthy Male and Female Volunteers
NCT02969252 ·Status: COMPLETED ·Phase: PHASE1
-
An Open, Prospective, Randomized, Multicenter Study of the Efficacy and Safety of Intravenous Followed by Oral Azithromycin Versus Cefuroxime Alone or With Oral Erythromycin for the Treatment of Chinese Patients Who Were Hospitalized for Pneumonia
NCT00648726 ·Status: COMPLETED ·Phase: PHASE3
-
Nitazoxanide Versus Placebo for the Treatment of Hospitalized Subjects With Severe Acute Respiratory Illness
NCT02057757 ·Status: COMPLETED ·Phase: PHASE2
-
"Sexual Health Assessment of TinidaZole Against M. Genitalium (SHAZAM)"
NCT07088419 ·Status: RECRUITING ·Phase: PHASE2